Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Argus Health
Merck
Federal Trade Commission
Cerilliant
Harvard Business School
US Army
Chinese Patent Office

Generated: July 21, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE

« Back to Dashboard

Clinical Trials for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE

Trial ID Title Status Sponsor Phase Summary
NCT00774280 Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen Completed Cooperative Study Group A for Hematology Phase 3 1. At the same time of registration, patients will be randomized to one of the two conditioning therapy groups; Arm I (intravenous busulfan plus cyclophosphamide; BuCy) or Arm II (intravenous busulfan plus fludarabine; BuFlu). 2. Randomization will be a stratified permuted-block design. 2.1The patients will be stratified into standard risk vs. high risk group, and related vs. unrelated donor. Standard risk group will be defined as follows: patients with acute leukemia in first remission, CML in chronic phase, and MDS (RA or RARS categories). High risk group will be defined as follows: patients with acute leukemia in relapse or in second or subsequent remission, CML in accelerated or blastic phase, and MDS (CMMoL or RAEB categories). 2.2.Pre-assigned block size is 8.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Clinical Trial Conditions for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE

Condition Name

Condition Name for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Intervention Trials
Leukemia 1
Myelodysplastic Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Intervention Trials
Leukemia 1
Syndrome 1
Preleukemia 1
Myelodysplastic Syndromes 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE

Trials by Country

Trials by Country for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Location Trials
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE

Clinical Trial Phase

Clinical Trial Phase for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Clinical Trial Phase Trials
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE

Sponsor Name

Sponsor Name for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Sponsor Trials
Cooperative Study Group A for Hematology 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE
Sponsor Trials
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKesson
Covington
Queensland Health
US Army
Healthtrust
Cerilliant
Citi
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.